Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

Natural honey protects against Doxorubicin's harmful effects.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

The treatment is safe and shows promise for metastatic breast cancer.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

FA-MNPs effectively targeted and killed cancer cells but didn't overcome drug resistance.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Doxorubicin can block blood vessels from hair follicles, reducing skin tumor growth.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

A special gel with medicine helps prevent melanoma from coming back after surgery.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Nanostructured lipid carriers deliver lidocaine to the skin better than nanoethosomes.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.